1567. Pharmacokinetic/Pharmacodynamic Target Attainment in Adult and Pediatric Patients following Administration of Ceftaroline Fosamil as a 5-Minute Infusion

BACKGROUND: Ceftaroline fosamil is approved in the United States for treating patients ≥2 months old with acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia, and for similar indications in Europe. The active metabolite, ceftaroline, has in vitro activity ag...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Open Forum Infect Dis
Glavni autori: Riccobene, Todd, ScD, T J Carrothers, Knebel, William, Raber, Susan, Chan, Phylinda L S
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809530/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1431
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items